Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

Next‐generation sequencing (NGS) and digital PCR technologies allow analysis of the mutational profile of circulating cell‐free DNA (cfDNA) in individuals with advanced lung cancer. We have now evaluated the feasibility of cfDNA sequencing for mutation detection in patients with non‐small cell lung...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Sci
Hlavní autoři: Ohira, Tatsuo, Sakai, Kazuko, Matsubayashi, Jun, Kajiwara, Naohiro, Kakihana, Masatoshi, Hagiwara, Masaru, Hibi, Masaaki, Yoshida, Koichi, Maeda, Junichi, Ohtani, Keishi, Nagao, Toshitaka, Nishio, Kazuto, Ikeda, Norihiko
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5132294/
https://ncbi.nlm.nih.gov/pubmed/27575703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13068
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky